Schedule 13G ownership disclosure

NEWAMSTERDAM PHARMA COMPANY

Ordinary Shares, nominal value EUR0.12 per share · CUSIP: N62509109

Event date: 2025-03-31

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares
Unavailable
Percent of class
Unavailable
  • RA Capital Management, L.P.

    Shares: 11,063,125.00 · Class: 9.9%

  • Peter Kolchinsky

    Shares: 11,063,125.00 · Class: 9.9%

  • Rajeev Shah

    Shares: 11,063,125.00 · Class: 9.9%

  • RA Capital Healthcare Fund, L.P.

    Shares: 11,063,125.00 · Class: 9.9%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001415889-25-013208
Form type
SCHEDULE 13G/A
Filer
NewAmsterdam Pharma Co N.V.
CIK
CIK 1936258
Filed
May 15, 2025
Reporting period
Mar 31, 2025
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub